These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36227719)

  • 1. COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system.
    Karako K; Song P; Chen Y; Karako T
    J Glob Health; 2022 Oct; 12():03073. PubMed ID: 36227719
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible contact transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings in Japan, 2020-2021.
    Kurosu H; Watanabe K; Kurosawa K; Nakashita M; Kasamatsu A; Nakamura H; Yamagishi T; Mitsuhashi Y; Yano K; Hachiya Y; Odani T; Amishima M; Nekomiya Y; Matsui T; Yamada M; Kamiyama K; Kikuchi T; Takadate K; Watanabe C; Furusawa Y; Kase K; Hyodo Y; Suzuki H; Matsunaga T; Hori H; Kanoh M; Miyake Y; Yamada M; Kobayashi Y; Sugai M; Suzuki M; Sunagawa T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1296-1298. PubMed ID: 34039453
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental Investigation of SARS-CoV-2 in a Karaoke Bar: a Survey for a Cluster of COVID-19 in Hokkaido, Japan, 2020.
    Miyoshi M; Komagome R; Yamaguchi H; Yoshizumi S; Ishida S; Nagano H; Katamoto K; Okubo K; Goto A; Mitsuhashi K; Tanaka H; Shibata K; Shibuma T; Yamaya S; Tsuda S; Kuzuma A; Sadamoto T; Ohara T; Yamano K
    Jpn J Infect Dis; 2021 Sep; 74(5):495-497. PubMed ID: 33642436
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.
    Morikane K; Satoh N; Hatano K; Kanouchi K; Kakehata S; Satoh S; Uyeki TM; Ueno Y
    Western Pac Surveill Response J; 2021; 12(1):69-71. PubMed ID: 34094628
    [No Abstract]   [Full Text] [Related]  

  • 5. Further promotion of "the JSH plan for the future" conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension.
    Rakugi H
    Hypertens Res; 2021 Jan; 44(1):4-6. PubMed ID: 33398127
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of Health Care-associated Novel Coronavirus (SARS-coV-2) COVID-19 infections in the Spring of 2020.
    Kitagawa Y
    Keio J Med; 2021; 70(1):1-6. PubMed ID: 33762512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID lessons from Japan: the right messaging empowers citizens.
    Oshitani H
    Nature; 2022 May; 605(7911):589. PubMed ID: 35606523
    [No Abstract]   [Full Text] [Related]  

  • 8. Nosocomial SARS-CoV-2 Infections in Japan: A Cross-sectional Newspaper Database Survey.
    Tani Y; Sawano T; Kawamoto A; Ozaki A; Tanimoto T
    Int J Health Policy Manag; 2020 Oct; 9(10):461-463. PubMed ID: 32610801
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter from Japan: Re-thinking our future.
    Hashimoto S; Hikichi M; Maruoka S; Gon Y
    Respirology; 2021 Feb; 26(2):208-209. PubMed ID: 33295008
    [No Abstract]   [Full Text] [Related]  

  • 10. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Matsumura Y; Nagao M; Yamamoto M; Tsuchido Y; Noguchi T; Shinohara K; Yukawa S; Inoue H; Ikeda T
    Emerg Infect Dis; 2022 Aug; 28(8):1569-77. PubMed ID: 35710464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of  SARS-CoV-2 super-spreaders in Japan.
    Kawahara T; Ueki Y; Nawa N; Miyamae S; Hanafusa M; Goto Y; Tohda S; Fujiwara T
    J Infect; 2022 Feb; 84(2):e6-e9. PubMed ID: 34974057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
    Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
    Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Public Health Centers and Cluster-Based Approach for COVID-19 Response in Japan.
    Imamura T; Saito T; Oshitani H
    Health Secur; 2021; 19(2):229-231. PubMed ID: 33346703
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 15. Trust is a key factor in the willingness of health professionals to work during the COVID-19 outbreak: Experience from the H1N1 pandemic in Japan 2009.
    Imai H
    Psychiatry Clin Neurosci; 2020 May; 74(5):329-330. PubMed ID: 32105381
    [No Abstract]   [Full Text] [Related]  

  • 16. Cluster-Based Approach to Coronavirus Disease 2019 (COVID-19) Response in Japan, from February to April 2020.
    Oshitani H;
    Jpn J Infect Dis; 2020 Nov; 73(6):491-493. PubMed ID: 32611985
    [No Abstract]   [Full Text] [Related]  

  • 17. The COVID-19 Impact and Culture Nexus in Japan: Insights for the Global Community.
    Pratt CB; Carr RL
    Front Public Health; 2022; 10():879653. PubMed ID: 35615049
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan.
    Horita N
    Eur J Cancer; 2022 Apr; 165():113-115. PubMed ID: 35231766
    [No Abstract]   [Full Text] [Related]  

  • 19. Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan?
    Kaku N; Ota K; Sasaki D; Akamatsu N; Uno N; Sakamoto K; Kosai K; Hasegawa H; Izumikawa K; Mukae H; Yanagihara K
    Microbes Infect; 2021; 23(4-5):104812. PubMed ID: 33781868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral factors associated with SARS-CoV-2 infection in Japan.
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Yanagisawa N; Nagura Y; Kato Y; Kato H; Ueda A; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Miyahara R; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Influenza Other Respir Viruses; 2022 Sep; 16(5):952-961. PubMed ID: 35470969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.